Letter: changes in FIB-4 cut-off points for viral hepatitis – authors’ reply.

Surana P, Takyar V, Koh C et al.

Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Alimentary pharmacology & therapeutics. Apr 2017.

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Notify me of follow-up comments by email.

Notify me of new posts by email.